Unknown

Dataset Information

0

The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program.


ABSTRACT: Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77?±?7?kg) were administered the BA, Ractopamine (20?ppm in feed), or the recombinant growth hormone (GH), Reporcin (10?mg/48?hrs injected) for 1, 3, 7, 13 (n?=?10 per treatment, per time point) or 27 days (n?=?15 per treatment). Using RNA-sequencing and inferred pathway analysis, we examined temporal changes to the Longissimus Dorsi skeletal muscle transcriptome (n?=?3 per treatment, per time point) relative to a feed-only control cohort. Gene expression changes were affirmed by quantitative-PCR on all samples (n?=?164). RNA-sequencing analysis revealed that BA treatment had greater effects than GH, and that asparagine synthetase (Asns) was the 5th most significantly increased gene by BA at day 3. ASNS protein expression was dramatically increased by BA treatment at day 7 (p?

SUBMITTER: Brown D 

PROVIDER: S-EPMC6206132 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Beta-adrenergic agonist, Ractopamine, increases skeletal muscle expression of Asparagine Synthetase as part of an integrated stress response gene program.

Brown David D   Ryan Kevin K   Daniel Zoe Z   Mareko Molebeledi M   Talbot Richard R   Moreton Joanna J   Giles Tom C B TCB   Emes Richard R   Hodgman Charlie C   Parr Tim T   Brameld John M JM  

Scientific reports 20181029 1


Synthetic beta-adrenergic agonists (BA) have broad biomedical and agricultural application for increasing lean body mass, yet a poor understanding of the biology underpinning these agents is limiting further drug discovery potential. Growing female pigs (77 ± 7 kg) were administered the BA, Ractopamine (20 ppm in feed), or the recombinant growth hormone (GH), Reporcin (10 mg/48 hrs injected) for 1, 3, 7, 13 (n = 10 per treatment, per time point) or 27 days (n = 15 per treatment). Using RNA-seque  ...[more]

Similar Datasets

| S-EPMC7818274 | biostudies-literature
| S-EPMC9478401 | biostudies-literature
| S-EPMC3854871 | biostudies-literature
| S-EPMC10145675 | biostudies-literature
| S-EPMC8080640 | biostudies-literature
| S-EPMC6221361 | biostudies-literature
| S-EPMC8262305 | biostudies-literature
| S-EPMC6310878 | biostudies-literature
| S-EPMC5723983 | biostudies-literature
| S-EPMC4486270 | biostudies-literature